Bharat Parenterals Ltd — Important, 28-11-2025: Company Update

Bharat Parenterals' subsidiary, Innoxel Lifesciences, has successfully completed an EU GMP inspection by Belgium's FAMHP at its Vadodara manufacturing facility. The audit concluded with zero critical and zero major observations, a strong validation of the company's robust quality systems. This milestone significantly enhances Innoxel's regulatory credentials and strengthens its position in regulated international markets, building on prior successful USFDA inspections. Management highlights this achievement as key to expanding global market reach and achieving long-term strategic growth.